Early Results Of Coronary Artery Reconstruction For Extensive Coronary Disease
Sponsor
Sohag University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05891392
Collaborator
(none)
100
1
23
4.4
Study Details
Study Description
Brief Summary
Evaluation of early outcome obtained from coronary reconstruction with or without endarterectomy in extensive diseased coronary arteries
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
100 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Early Results Of Coronary Artery Reconstruction For Extensive Coronary Disease
Actual Study Start Date
:
Jan 1, 2022
Anticipated Primary Completion Date
:
Jun 1, 2023
Anticipated Study Completion Date
:
Dec 1, 2023
Outcome Measures
Primary Outcome Measures
- Free from ischemia [6 Months]
Good Revascularisation
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Primary elective CABG patients Patch anastomosis more than 2 cm
Exclusion Criteria:
- Patients with combined valvular procedure. Previous open heart surgery Patients with EF <40%
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Sohag university | Sohag | Egypt | 1670005 |
Sponsors and Collaborators
- Sohag University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Alaa Mahmoud Ibrahim,
Assistant lecturer,
Sohag University
ClinicalTrials.gov Identifier:
NCT05891392
Other Study ID Numbers:
- Soh-Med-23-5-01MD
First Posted:
Jun 6, 2023
Last Update Posted:
Jun 6, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: